GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lionco Pharmaceutical Group Co Ltd (SHSE:603669) » Definitions » E10

Lionco Pharmaceutical Group Co (SHSE:603669) E10 : ¥0.15 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Lionco Pharmaceutical Group Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Lionco Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥-0.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.15 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Lionco Pharmaceutical Group Co's average E10 Growth Rate was -31.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-27), Lionco Pharmaceutical Group Co's current stock price is ¥4.29. Lionco Pharmaceutical Group Co's E10 for the quarter that ended in Mar. 2024 was ¥0.15. Lionco Pharmaceutical Group Co's Shiller PE Ratio of today is 28.60.

During the past 13 years, the highest Shiller PE Ratio of Lionco Pharmaceutical Group Co was 38.00. The lowest was 20.59. And the median was 24.14.


Lionco Pharmaceutical Group Co E10 Historical Data

The historical data trend for Lionco Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lionco Pharmaceutical Group Co E10 Chart

Lionco Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.15

Lionco Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.21 0.23 0.15 0.15

Competitive Comparison of Lionco Pharmaceutical Group Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Lionco Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lionco Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lionco Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Lionco Pharmaceutical Group Co's Shiller PE Ratio falls into.



Lionco Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lionco Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.02/114.6694*114.6694
=-0.020

Current CPI (Mar. 2024) = 114.6694.

Lionco Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201406 0.082 98.200 0.096
201409 0.044 98.900 0.051
201412 0.102 99.000 0.118
201503 0.051 99.900 0.059
201506 0.077 99.500 0.089
201509 0.040 100.500 0.046
201512 0.080 100.600 0.091
201603 0.036 102.200 0.040
201606 0.066 101.400 0.075
201609 0.040 102.400 0.045
201612 0.073 102.600 0.082
201703 0.040 103.200 0.044
201706 0.042 103.100 0.047
201709 0.051 104.100 0.056
201712 0.087 104.500 0.095
201803 0.046 105.300 0.050
201806 0.054 104.900 0.059
201809 0.136 106.600 0.146
201812 0.021 106.500 0.023
201903 0.050 107.700 0.053
201906 0.100 107.700 0.106
201909 0.060 109.800 0.063
201912 0.070 111.200 0.072
202003 0.090 112.300 0.092
202006 0.020 110.400 0.021
202009 0.110 111.700 0.113
202012 0.000 111.500 0.000
202103 0.050 112.662 0.051
202106 0.040 111.769 0.041
202109 0.010 112.215 0.010
202112 -0.020 113.108 -0.020
202203 0.030 114.335 0.030
202206 0.020 114.558 0.020
202209 -0.150 115.339 -0.149
202212 -0.170 115.116 -0.169
202303 -0.030 115.116 -0.030
202306 -0.070 114.558 -0.070
202309 -0.030 115.339 -0.030
202312 -0.080 114.669 -0.080
202403 -0.020 114.669 -0.020

Add all the adjusted EPS together and divide 10 will get our e10.


Lionco Pharmaceutical Group Co  (SHSE:603669) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Lionco Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=4.29/0.15
=28.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Lionco Pharmaceutical Group Co was 38.00. The lowest was 20.59. And the median was 24.14.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Lionco Pharmaceutical Group Co E10 Related Terms

Thank you for viewing the detailed overview of Lionco Pharmaceutical Group Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Lionco Pharmaceutical Group Co (SHSE:603669) Business Description

Traded in Other Exchanges
N/A
Address
68 Zetang Nedong commercial building, 2nd Floor, Shannan Prefecture, CHN
Lionco Pharmaceutical Group Co Ltd is engaged in the research and development of medicines. The product portfolio includes - Alanyl glutamine for injection, fructose for injection, inverted sugar for injection, xylitol for injection, riboflavin sodium phosphate for injection, and water-soluble vitamin for injection.

Lionco Pharmaceutical Group Co (SHSE:603669) Headlines

No Headlines